SLC5A2 and metabolic dysfunction-associated steatotic liver disease: Electronic database, Google Scholar, and a WHO website were searched with keywords such as EMPA, SGLT-2 inhibitor, prediabetic and nondiabetic, nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), hepatic lipid metabolism, IR, hepatic steatosis, and obesity.